Clinical Trial Update: Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pazopanib in combination with lapatinib in adults with relapsed malignant glioma; the study is completed and results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Lapatinib (Lapatinib)
• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Glioma | Phase 2 | Status: COMPLETED | Results posted: 2011-06-20